Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial

Circulation

Volumn 111, Issue 17, 2005, Pages 2233-2240

  Markus, Hugh S ^a   Droste, Dirk W ^b,c   Kaps, Manfred ^d   Larrue, Vincent ^e   Lees, Kennedy R ^f   Siebler, Mario ^g   Ringelstein, E Bernd ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Carotid arteries; Embolism; Stroke; Trials; Ultrasonics

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; EMBOLISM; EPISTAXIS; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ASPIRIN; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; DRUG MONITORING; DRUG THERAPY, COMBINATION; EMBOLISM; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 18244404294     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000163561.90680.1C     Document Type: Article

References (39)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
2. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-2906.
3. Coull AJ, Lovett JK, Rothwell PM. Oxford Vascular Study: Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326.
4. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology. 2004;62:569-573.
5. Russell D, Madden KP, Clark WM, Sandset PM, Zivin JA. Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke. 1991;22:253-258.
6. Markus HS, Loh A, Brown MM. Detection of circulating cerebral emboli using transcranial Doppler ultrasound in a sheep model. J Neurol Sci. 1994;122:117-124.
7. Markus HS. Monitoring embolism in real time. Circulation. 2000;102:826-828.
8. Siebler M, Kleinschmidt A, Sitzer M, Steinmetz H, Freund HJ. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology. 1994;44:615-618.
9. Markus HS, Thomson N, Brown MM. Asymptomatic cerebral embolic signals in symptomatic and asymptomatic carotid artery disease. Brain. 1995;118:1005-1011.
10. Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke. 1999;30:1440-1443.
11. Georgiadis D, Lindner A, Manz M, Sonntag M, Zunker P, Zerkowski HR, Borggrege M. Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls. Stroke. 1997;28:1203-1207.
12. Droste DW, Dittrich R, Kemeny V, Schulte-Altedorneberg G, Ringelstein EB. Prevalence and frequency of microembolic signals in 105 patients with extracranial carotid artery occlusive disease. J Neurol Neurosurg Psychiatry. 1999;67:525-528.
13. Siebler M, Sitzer M, Rose G, Bendfeldt D, Steinmetz H. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis: event rates before and after carotid endarterectomy. Brain. 1993;116:1005-1015.
14. Sitzer M, Muller W, Siebler M, Hort W, Kniemeyer HW, Jancke L, Steinmetz H. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke. 1995;26:1231-1233.
15. Valton L, Larrue V, Arrue P, Geraud G, Bes A. Asymptomatic cerebral embolic signals in patients with carotid stenosis: correlation with the appearance of plaque ulceration on angiography. Stroke. 1995;26:813-815.
16. Siebler M, Nachtmann A, Sitzer M, Rose G, Kleinschmidt A, Rademacher J, Steinmetz H. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery ischemia. Stroke. 1995;26:2184-2186.
17. Valton L, Larrue V, Le Traon AP, Massabuau P, Gerard G. Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke. 1998;29:2125-2128.
18. Censori B, Partziguian T, Castro L, Camerlingo M, Mamoli A. Doppler microembolic signals predict ischaemic recurrences in symptomatic carotid stenosis. Acta Neurol Scand. 2000;101:327-331.
19. Goertler M, Blaser T, Krueger S, Hofmann K, Baeumer M, Wallesch CW. Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry. 2002;72:338-342.
20. Goertler M, Baeumer M, Kross R, Blaser T, Lutze G, Jost S, Wallesch CW. Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acid. Stroke. 1999;30:66-69.
21. Kaposzta Z, Martin JF, Markus HS. Switching off embolization from symptomatic carotid plaque using S-nitrosoglutathione. Circulation. 2002;105:1480-1484.
22. Junghans U, Siebler M. Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation. 2003;107:2717-2721.
23. Herbert JM, Dol F, Bernat A, Falotico R, Lale A, Savi P. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost. 1988;80:512-518.
24. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
25. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
26. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, for the CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation. 2000;102:624-629.
27. Diener H-C, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht H-J, on behalf of the MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
28. De Bray JM, Glatt B. Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis. 1995;5:414-426.
29. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
30. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russell D, Siebler M, for the International Consensus Group on Microembolus Detection. Consensus on microembolus detection by TCD. Stroke. 1998;29:725-729.
31. Markus HS, Bland JM, Rose G, Sitzer M, Siebler M. How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke. 1996;27:1249-1252.
32. Born GVR, Cross JM. The aggregation of blood platelets. J Physiol. 1963;168:178-195.
33. Ruggeri ZM. New insights into the mechanisms of platelet adhesion and aggregation. Semin Haematol. 1994;31:229-239.
34. ESPS2 Group. European Stroke Prevention Study 2: efficacy and safety data. J Neurol Sci. 1997;151(suppl):S1-S77.
35. Rothwell PM. Lessons from MATCH for future randomised trials in secondary prevention of stroke. Lancet. 2004;364:305-307.
36. David A. Payne DA, Jones CI, Hayes PD, Thompson MM, London NJ, Bell PR, Goodall AH, Naylor AR. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation. 2004;109:1476-1481.
37. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results in the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
38. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:450-453.
39. Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000;101:2823-2828.